1 |
Korea Centers for Disease Prevention and Control. 2013. Monitoring of antimicrobial resistance on non-tertiary hospitals in Korea, 2007-2011, Annual report. 12-21.
|
2 |
Ruppe, E., Bidet, P., Verdet, C., Arlet, G., and Bingen, E. 2006. First detection of the Ambler class C1 AmpC -lactamases in Citrobacter frunddii by a new, simple double-disk synergy test. J. Clin. Microbiol. 44, 4204-4207.
DOI
ScienceOn
|
3 |
Shin, K.S. and Son, B.R. 2002. Comparison of Vitek ESBL test and other methods for detecting extended-spectrum -lactamase producing Escherichia coli and Klebsiella species. Korean J. Clin. Pathol. 22, 21-26.
|
4 |
Silva, J., Gatica, R., Aguilar, C., Becerra, Z., Garza-Ramos, U., Velazquez, M., Miranda, G., Leanos, B., Solorzano, F., and Echaniz, G. 2001. Outbreak of infection with extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a Mexican hospital. J. Clin. Microbiol. 39, 3193-3196.
DOI
ScienceOn
|
5 |
Steward, C.D., Rasheed, K., Hubert, S.K., Biddle, J.W., Raney, P.M., Anderson, G.J., Williams, P.P., Brittain, K.L., Oliver, A., McGowan, J.E. Jr., Tenover, F.C., and et al. 2001. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum -lactamase detection methods. J. Clin. Microbiol. 39, 2864-2872.
DOI
ScienceOn
|
6 |
Lee, B.Y., Jeong, S.H., Jeong, T.S., Nam, H.J., Ji, J.H., and Hong, Y.R. 2001. Detection of extended-spectrum -lactamase producing Escherichia coli and Klebsiella spp. with the Vitek GNS 121 card. Korean J. Clin. Pathol. 21, 350-354.
|
7 |
Lee, J.H., Bae, I.K., Kwon, S.B., Jeong, S.H., Woo, G.J., Lee, J.W., Lee, W.G., Kang, J.O., Ahn, J.Y., Hong, S.G., and et al. 2004. Prevalence of CTX-M-type extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea, 2003. Korean J. Clin. Microbiol. 7, 111-118.
|
8 |
Lee, K.W., Jo, S.R., Lee, C.S., Jung, Y.S., and Gwon, O.H. 1996. Extended spectrum -lactamase producing Escherichia coli and Klebsiella pneumoniae. Infection 26, 341-348.
|
9 |
Monica, C., Sonia, M.T., Alejandro, P., Angeles, B.N., David, D., Francisca, V., Rosa, M., and German, V. 2004. Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins. J. Clin. Microbiol. 42, 42-49.
|
10 |
Pai, H.J. 1998. The characteristics of extended-spectrum -lactamases in Korean isolates of Enterobacteriaceae. Yonsei Med. J. 39, 514-519.
DOI
ScienceOn
|
11 |
Edelstein, M., Pimkin, M., Palagin, I., Edelstein, I., and Stratchounski, L. 2003. Prevalence and molecular epidemiology of CTX-M extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother. 47, 3724-3732.
DOI
ScienceOn
|
12 |
Park, J.H., Lee, S.H., Jeong, S.H., Kim, B.N., Kim, K.B., Yoon, J.D., and Jeon, B.C. 2003. Characterization and prevalence of Escherichia coli and Klebsiella pneumoniae isolates producing an extendedspectrum -lactamase from Korean hospitals. Korean J. Lab. Med. 23, 18-24.
|
13 |
Poirel, L., Naas, T., Guibert, M., Chaibi, E.B., Labia, R., and Nordmann, P. 1999. Molecular and biochemical characterization of VEB, a novel class an extended-spectrum -lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43, 573-581.
|
14 |
Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing, Document M100-S21. CLSI. Wayne, Pensylvania, USA.
|
15 |
Hong, S.G., Kang, M.S., Choi, J.R., Lee, K.W., Chong, Y.S., and Kwon, O.H. 2001. Molecular characteristics of extended-spectrum -lactamases in clinical isolates of Enterobacteriaceae. Korean J. Clin. Pathol. 21, 495-504.
|
16 |
Jacoby, G.A. and Medeiros, A.A. 1991. More extended-spectrum -latamases. Antimicrob. Agents Chemother. 35, 1697-1704.
DOI
ScienceOn
|
17 |
Jarlier, V., Nicolas, M.H., Fournier, G., and Philippon, A. 1988. Extended broadspectrum -lactamases conferring transferable resistance to newer -lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10, 867-878.
DOI
|
18 |
Bradford, P.A. 2001. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933-951.
DOI
ScienceOn
|